Turn Therapeutics Inc. (TTRX)
Nasdaq: TTRX · Pharmaceutical Preparations · Westlake Village, CA · filing with the SEC since 2024
Who owns Turn Therapeutics Inc.
As filed with the SECHolders of 5% or more
1
Bradley Burnam holds 52.8% of common stock, as its SCHEDULE 13G filed Apr 6, 2026 says.
Directors and officers
7
report now, of 7 people on the record since 2025. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Bradley Burnam
SCHEDULE 13G · filed Apr 6, 2026 · common stock
What TTRX reports owning in othersstakes of 5% or more, and other ties
Turn Therapeutics Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
8purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 9 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Chaudhary Zuraiz | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | 0 | $0 | 0 | 5 | $0 |
| Golden Arthur F | director | 0 | $0 | 0 | 3 | $200,000 |
| Chesed Abraham | other | 0 | $0 | 0 | 1 | $100,000 |